Star Health fined ₹2 crore by IRDAI for claim settlement issues in 2022 inspection
Star Health & Allied Insurance Company · Insurance
Key highlights
- Penalty of ₹2 crore imposed under IRDAI (Health Insurance) Regulations, 2016, received on Nov 20, 2026
- Penalty relates to claims settlement inspected by IRDAI between Jan 31 and Feb 11, 2022
- Company states penalty is financial only with no impact on operations; currently evaluating response options
Original filing
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Engineering Services
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Star Health & Allied Insurance Company
Other other filings this fortnight
- Protean eGov Technologies receives upheld GST penalty order dated Nov 17, 2026
- OtherSML MahindraMahindra & Mahindra Limited files Rights Issue Letter of Offer dated Nov 16, 2026
- OtherEasy Trip PlannersEasy Trip Planners Limited releases Q2 and H1 FY 2026 financial results and announces CMO resignation
- Salasar Techno Engineering Limited reports Q2 & H1 FY27 financial results and disclosures
- OtherEKI Energy ServicesEKI Energy Services Limited announces Q2 and H1 FY2027 unaudited financial results
- Reliance Infrastructure Ltd reports financial results and regulatory updates for Q2 FY 2026-27
Potential multibaggers · Q2 FY27
Potential multibaggers in Insurance
on management's own guidance
- Max FinancialModerate growth2
- Niva Bupa HealthGood growth1
- HDFC Life Insurance CompanyModerate growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
